1. Comparison of cell membrane damage induced by the therapeutic ultrasound on human breast cancer MCF-7 and MCF-7/ADR cells
    Yali Jia et al, 2015, Ultrasonics Sonochemistry CrossRef
  2. Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells
    Zhangfeng Zhong et al, 2018, Chinese Medicine CrossRef
  3. Germacrone derivatives: synthesis, biological activity, molecular docking studies and molecular dynamics simulations
    Jie Wu et al, 2017, Oncotarget CrossRef
  4. Biological Activities of Non-curcuminoids
    Swee Keong Yeap et al, 2020, The Chemistry and Bioactive Components of Turmeric CrossRef
  5. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression
    Jia Pan et al, 2018, Chemico-Biological Interactions CrossRef
  6. Germacrone cooperates with dexmedetomidine to alleviate high‑fat diet‑induced type 2 diabetes mellitus via upregulating AMPKα1 expression
    Yang Sun et al, 2019, Experimental and Therapeutic Medicine CrossRef
  7. Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations
    Akhila Nair et al, 2019, Biomolecules CrossRef
  8. Germacrone attenuates cerebral ischemia/reperfusion injury in rats via antioxidative and antiapoptotic mechanisms
    Tianhui Wu et al, 2019, Journal of Cellular Biochemistry CrossRef
  9. Germacrone alleviates breast cancer‐associated osteolysis by inhibiting osteoclastogenesis via inhibition of MAPK/NF‐κB signaling pathways
    Zhengjun Lin et al, 2024, Phytotherapy Research CrossRef
  10. Germacrone protects against oxygen-glucose deprivation/reperfusion injury by inhibiting autophagy processes in PC12 cells
    Jianxing Zhang et al, 2020, BMC Complementary Medicine and Therapies CrossRef
  11. Optimization and in vitro antiproliferation of Curcuma wenyujin’s active extracts by ultrasonication and response surface methodology
    Xiaoqin Wang et al, 2016, Chemistry Central Journal CrossRef
  12. Germacrone, A Novel and Safe Anticancer Agent from Genus Curcuma: A Review of its Mechanism
    Guanhua Lou et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  13. Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer
    Peng Zhao et al, 2023, Phytomedicine CrossRef
  14. Germacrone: A Potent Secondary Metabolite with Therapeutic Potential in Metabolic Diseases, Cancer and Viral Infections
    Ammara Riaz et al, 2020, Current Drug Metabolism CrossRef
  15. Understanding dihydro-β-agarofuran sesquiterpenes from Tripterygium hypoglaucum as the modulators of multi-drug resistance in HepG2/Adr cells
    Tao Yang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  16. Curcuma longa
    T. K. Lim, 2016, Edible Medicinal and Non-Medicinal Plants CrossRef
  17. Curcuma and Breast Cancer: A Focus on Cell Signaling Pathways
    Azhar Rasul et al, 2021, Nutraceuticals and Cancer Signaling CrossRef
  18. Germacrone Inhibits Cell Proliferation and Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cells
    Ren Zhang et al, 2020, BioMed Research International CrossRef
  19. Efficacy of traditional Chinese medicine in treating cancer
    JIAO NIE et al, 2016, Biomedical Reports CrossRef
  20. Antiproliferative activity of Curcuma phaeocaulis Valeton extract using ultrasonic assistance and response surface methodology
    Xiaoqin Wang et al, 2017, Preparative Biochemistry & Biotechnology CrossRef
  21. Terpenoids from Curcumae Rhizoma: Their anticancer effects and clinical uses on combination and versus drug therapies
    Yi Chen et al, 2021, Biomedicine & Pharmacotherapy CrossRef